Latest News

March 02.2010
Interim Results and £2.0 million Fundraising
Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines announces interim results for the six months ended 31 December 2009. ...read more

Other news stories
- Preliminary Results for the year ended 30 June 2009 - Confirmation of Management Change - European Patent Granted For MPL-Based Sublingual Vaccines - Proposed Placing and Subscription Offer to Qualifying Participants Approval of waiver of Takeover Code Rule 9 and Notice of General Meeting - Distribution Agreement with Nycomed for Pollinex® R in Canada

View all news